Topic: atrial fibrillation
AliveCor kicked off Black Friday sales of its FDA-cleared KardiaMobile ECG heart monitoring device with a new celebrity spokesman.
Bristol-Myers Squibb and Pfizer's Eliqus has taken the U.S. warfarin alternative market by storm, but can afib screening amp it up even more?
Eliquis has new data showing the next-gen anticoagulant is safer than warfarin for a tough-to-treat group of atrial fibrillation patients.
Pfizer and Bristol-Myers Squibb's latest campaign looks to raise awareness about the connection between atrial fibrillation and stroke risk.
What’s in a name? Well, when that name is iHeart, an open door for Pfizer and Bristol-Myers Squibb to promote atrial fibrillation awareness.
Direct oral anticoagulants haven’t made the mark cardiology professionals had hoped in atrial fibrillation patients.
Only one of the three leading next-gen anticoagulants showed it could save the healthcare system hundreds of dollars per patient in a new real-world study.